Catalyst Wire Dossier Catalyst Wire Dossier

Promacta

eltrombopag · Novartis
Drug timelines are a Plus or Pro feature.

69 regulatory and trial events tracked for Promacta, covering 2008-11-20 to 2026-02-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Effectiveness of Eltrombopag in Combination With Immunosuppressive Therapy (IST) in Korean Pediatric Patients With Treatment Naïve Severe Aplastic Anemia

See pricing